Acute Electroconvulsive Therapy Followed by Maintenance Electroconvulsive Therapy Decreases Hospital Re-Admission Rates of Older Patients With Severe Mental Illness

Shelef, Assaf; Mazeh, Doron; Berger, Uri; Baruch, Yehuda; Barak, Yoram

doi:10.1097/yct.0000000000000197

Cited by 27 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Retrospective studies indicate that the use of continuation and maintenance ECT (C-ECT) is effective in terms of reducing the risk of relapse and readmission rates [31, 32]. Unfortunately, few prospective studies regarding maintenance in schizophrenia are available.…”

Section: Resultsmentioning

confidence: 99%

Electroconvulsive Therapy and Schizophrenia: A Systematic Review

Ali¹,

Mathur²,

Malhotra³

et al. 2019

Complex Psychiatry

View full text Add to dashboard Cite

Electroconvulsive therapy (ECT) is a remarkably effective treatment for major depressive disorder, but is less commonly utilized for treatment of psychotic disorders. Recent literature indicates that ECT can be a useful strategy for a wide range of psychotic disorders, including treatment-resistant schizophrenia. The purpose of this review is to examine the extant literature on ECT in schizophrenia with a primary focus on its efficacy, its impact on cognitive function, the role of maintenance ECT, and the potential role of neuroimaging biomarkers to provide more precise ECT treatment strategies. We evaluated the available literature, with a particular focus on prospective, randomized trials. Our review suggests that ECT can be an effective treatment strategy in this severely ill patient population. Studies suggest that while ECT in schizophrenia is a safe treatment modality, the potential for cognitive impairment must always be carefully weighed. The use and investigation of new biomarker strategies for the pharmacological treatment of schizophrenia, and the extension of these approaches to ECT are also discussed.

show abstract

Section: Resultsmentioning

confidence: 99%

Electroconvulsive Therapy and Schizophrenia: A Systematic Review

Ali¹,

Mathur²,

Malhotra³

et al. 2019

Complex Psychiatry

View full text Add to dashboard Cite

show abstract

“…There is growing evidence for M-ECT, with recent studies showing favorable clinical outcomes of M-ECT in MDD [59,60] and schizophrenia [61,62]. Some studies show that long-term maintenance has been shown to delay relapse into a depressive episode [63][64][65] and has led to significant decreases in hospitalization and resource utilization in chronically ill patients [66][67][68].…”

Section: Ect Protocolmentioning

confidence: 99%

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Stone

Collier

2020

Personalized Medicine in Psychiatry

View full text Add to dashboard Cite

“…A personalized treatment approach is suggested, with sessions delivered once a week, every two weeks or once a month [25]. The M-ECT treatment duration usually ranges from 6 to 12 months [26], but in some cases it was continued for 13.5 months [27], 19 months [28], or even 12 years [29]. Despite initial forebodings concern-poziom codziennego funkcjonowania.…”

Section: Commentmentioning

confidence: 99%

“…However, considering the scarcity of relevant reports in the literature, the method requires further evaluation and monitoring, particularly as regards the development of precise treatment regimens and long-term assessment of their safety. w miesiącu [25], stosowanymi zazwyczaj przez 6-12 miesięcy [26]; opisano również leczenie trwające 13,5 miesiąca [27], 19 miesięcy [28], a nawet 12 lat [29]. Mimo początkowych obaw co do możliwych działań niepożądanych, dane z literatury potwierdzają wysoki poziom bezpieczeństwa i małe ryzyko wystąpienia lub kumulacji zaburzeń procesów poznawczych podczas stosowania M-ECT [25,30].…”

Section: Komentarzunclassified

Clozapine and maintenance electroconvulsive therapy in a 35-year-old patient with treatment-resistant schizophrenia and chronic imperative auditory hallucinations

Zakowicz¹,

Wójciak²,

Dziuda³

et al. 2019

ppn

View full text Add to dashboard Cite

Purpose: Despite progress in the treatment of schizophrenia, treatment resistance is reported in about 30% of patients. Various forms of treatment augmentation are used, but clozapine is generally considered to be the gold standard of care. In the management of patients with clozapine resistance adjunctive electroconvulsive therapy (ECT) courses have been proposed. In recent years particular attention has been paid to augmentation of clozapine with the maintenance electroconvulsive therapy (M-ECT). Case description: The paper presents a patient with treatment-resistant schizophrenia and chronic psychotic symptoms leading to self-destructive and suicidal behaviors. After concurrent treatment with clozapine and M-ECT her clinical status and functioning have improved. Comment: Maintenance-ECT used to augment clozapine in drug-resistant schizophrenia seems to be a safe and promising management option.

show abstract

Acute Electroconvulsive Therapy Followed by Maintenance Electroconvulsive Therapy Decreases Hospital Re-Admission Rates of Older Patients With Severe Mental Illness

Abstract: Our findings suggest that acute ECT followed by M-ECT is highly effective in selected elderly patients with SMIs.

Cited by 27 publications

References 0 publications

Electroconvulsive Therapy and Schizophrenia: A Systematic Review

Electroconvulsive Therapy and Schizophrenia: A Systematic Review

Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

Clozapine and maintenance electroconvulsive therapy in a 35-year-old patient with treatment-resistant schizophrenia and chronic imperative auditory hallucinations

Contact Info

Product

Resources

About